Legends for Figures
Figure 1. Change in symptom score, quality of life and exhaled nitric oxide between baseline and follow up visits. (A) Symptom score (TRACK) at baseline (Visit 1) and follow-up (Visit 2), (B) Change in TRACK according to level of monitored adherence, (C) Parental and child quality of life questionnaire (PACQLQ) and (D) exhaled nitric oxide (FeNO) at baseline and follow up.
Figure 2. Change in symptom score in atopic and non-atopic symptom between baseline and follow up visit. (A) Symptom score at baseline and follow-up in atopic children, (B) non-atopic children.
Figure 3. Change in symptom score in atopic children according to level of adherence. Relationship between adherence and change in symptom score from baseline (Visit 1) to follow up (Visit 2) in atopic children with (A) > 60% adherence to inhaled corticosteroids and (B) <60% adherence to inhaled corticosteroids